RLYB
Rallybio Corp
Company overview
- Market capitalization
- $90.54M
- Employees
- 9
- Latest publication
- 2026-09-29
About Rallybio Corp
Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. The company has a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases, as well as collaboration agreement with Johnson & Johnson to provide therapeutic solutions for pregnant individuals at risk of fetal and neonatal alloimmune thrombocytopenia. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 38,000USD | 299,000USD | 299,000USD | 0USD | 228,000USD | 0USD | 0USD |
| Research Development | 758,000USD | 7,355,000USD | 8,240,000USD | 12,912,000USD | 12,901,000USD | 15,924,000USD | 13,288,000USD | 13,130,000USD |
| General And Administrative Expenses | 4,895,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 5,653,000USD | 11,616,000USD | 12,365,000USD | 17,300,000USD | 19,752,000USD | 21,112,000USD | 19,363,000USD | 20,083,000USD |
| Operating Income | -5,653,000USD | -11,608,000USD | -12,066,000USD | -17,035,000USD | -19,787,000USD | -21,112,000USD | -19,363,000USD | -20,083,000USD |
| Total Other Income Expense Net | 50,642,000USD | 564,000USD | 600,000USD | 799,000USD | 758,000USD | 870,000USD | 989,000USD | 1,453,000USD |
| Income Before Tax | 44,989,000USD | -11,044,000USD | -11,466,000USD | -16,236,000USD | -19,029,000USD | -20,242,000USD | -18,374,000USD | -18,630,000USD |
| Income Tax Expense | 1,324,000USD | -430,000USD | — | 487,000USD | 685,000USD | 613,000USD | -37,000USD | 217,000USD |
| Equity Method Income Loss | 0USD | — | — | — | — | — | — | — |
| Net Income | 43,665,000USD | -11,044,000USD | -11,466,000USD | -16,236,000USD | -19,029,000USD | -20,242,000USD | -18,374,000USD | -18,630,000USD |
| Cost Of Revenue | — | 30,000USD | 32,000USD | 34,000USD | 35,000USD | 114,000USD | 37,000USD | 38,000USD |
| Gross Profit | — | 8,000USD | 299,000USD | 265,000USD | -35,000USD | 114,000USD | -37,000USD | -38,000USD |
| Selling General Administrative | — | 4,261,000USD | 4,125,000USD | 4,388,000USD | 6,851,000USD | 5,188,000USD | 6,075,000USD | 6,953,000USD |
| Interest Income | — | 811,000USD | 986,000USD | 1,143,000USD | 1,276,000USD | 1,448,000USD | 1,545,000USD | 1,608,000USD |
| Net Interest Income | — | 811,000USD | 986,000USD | 1,143,000USD | 1,276,000USD | 1,448,000USD | 1,545,000USD | 1,608,000USD |
| Net Income From Continuing Ops | — | -11,044,000USD | -11,466,000USD | -16,236,000USD | -19,029,000USD | -20,242,000USD | -18,374,000USD | -18,413,000USD |
| Ebit | — | -11,608,000USD | -12,066,000USD | -17,035,000USD | -19,787,000USD | -21,112,000USD | -19,363,000USD | -20,083,000USD |
| Ebitda | — | -11,578,000USD | -12,034,000USD | -17,001,000USD | -19,752,000USD | -21,076,000USD | -19,326,000USD | -20,045,000USD |
| Depreciation And Amortization | — | 30,000USD | 32,000USD | 34,000USD | 35,000USD | 36,000USD | 37,000USD | 38,000USD |
| Reconciled Depreciation | — | 30,000USD | 32,000USD | 34,000USD | 35,000USD | 36,000USD | 37,000USD | 38,000USD |
| Interest Expense | — | — | — | — | — | 1,658,000USD | — | — |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 1,242,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | -18,630,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 858,000USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 92,000USD | 167,000USD | 62,030USD | 26,344USD |
| Gross Profit | 766,000USD | -167,000USD | -62,030USD | -26,344USD |
| Research Development | 19,597,000USD | 40,689,000USD | 17,630,000USD | 11,366,000USD |
| Selling General Administrative | 14,325,000USD | 27,195,000USD | 7,673,000USD | 6,276,000USD |
| Unclassified Operating Expenses | -5,092,000USD | — | — | — |
| Total Operating Expenses | 28,830,000USD | 67,884,000USD | 25,303,000USD | 17,642,000USD |
| Operating Income | -28,064,000USD | -67,884,000USD | -25,303,000USD | -17,642,000USD |
| Interest Income | 2,189,000USD | 1,963,000USD | 171,000USD | 197,000USD |
| Net Interest Income | 2,189,000USD | 1,963,000USD | 122,000USD | 158,000USD |
| Income Before Tax | -8,978,000USD | -67,729,000USD | -26,462,000USD | -17,460,000USD |
| Net Income | -8,978,000USD | -66,654,000USD | -26,447,000USD | -17,626,000USD |
| Net Income From Continuing Ops | -8,978,000USD | -65,579,000USD | -26,447,000USD | -17,563,000USD |
| Ebit | -28,064,000USD | -67,884,000USD | -25,303,000USD | -17,421,000USD |
| Ebitda | -27,972,000USD | -67,717,000USD | -25,241,000USD | -17,394,656USD |
| Depreciation And Amortization | 92,000USD | 167,000USD | 62,000USD | 26,344USD |
| Reconciled Depreciation | 92,000USD | 167,000USD | 62,000USD | 26,000USD |
| Total Other Income Expense Net | 19,086,000USD | 1,230,000USD | -1,159,000USD | 79,000USD |
| Interest Expense | — | 2,305,000USD | 49,000USD | 39,000USD |
| Income Tax Expense | — | -1,075,000USD | -15,000USD | 166,000USD |
| Non Operating Income Net Other | — | 1,016,000USD | — | — |
| Net Income Applicable To Common Shares | — | -66,654,000USD | -26,447,000USD | -17,563,000USD |
| Tax Provision | — | — | -15,000USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 98,063,000USD | 54,472,000USD | 62,261,000USD | 67,661,000USD | 51,003,000USD | 57,983,000USD | 68,108,000USD | 79,007,000USD |
| Cash And Equivalents | 92,849,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 92,849,000USD | 46,795,000USD | 54,736,000USD | 59,319,000USD | 45,749,000USD | 54,495,000USD | 65,511,000USD | 75,139,000USD |
| Short Term Investments | 0USD | 5,496,000USD | 23,362,000USD | 27,197,000USD | 36,304,000USD | 39,716,000USD | 51,608,000USD | 49,819,000USD |
| Total Current Assets | 97,253,000USD | 53,490,000USD | 61,253,000USD | 66,627,000USD | 50,265,000USD | 57,381,000USD | 67,841,000USD | 78,230,000USD |
| Other Current Assets | 4,404,000USD | 6,695,000USD | 6,517,000USD | 7,308,000USD | 4,516,000USD | 2,886,000USD | 2,330,000USD | 3,091,000USD |
| Other Non Current Assets | 810,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 3,567,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,567,000USD | 4,140,000USD | 4,223,000USD | 4,519,000USD | 5,039,000USD | 3,910,000USD | 6,242,000USD | 8,189,000USD |
| Other Current Liabilities | 1,465,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 94,496,000USD | 50,277,000USD | 57,956,000USD | 63,034,000USD | 45,964,000USD | 54,073,000USD | 61,654,000USD | 70,818,000USD |
| Total Equity Including Noncontrolling Interest | 94,496,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 0USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 0USD | 172,000USD | 198,000USD | 224,000USD | 112,000USD | 189,000USD | 267,000USD | 346,000USD |
| Accounts Payable | 833,000USD | 940,000USD | 126,000USD | 269,000USD | 119,000USD | 400,000USD | 278,000USD | 583,000USD |
| Short Term Debt | 0USD | 99,000USD | 94,000USD | 90,000USD | 58,000USD | 116,000USD | 154,000USD | 230,000USD |
| Common Stock | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Retained Earnings | -266,611,000USD | -310,276,000USD | -301,998,000USD | -296,146,000USD | -312,162,000USD | -302,459,000USD | -293,020,000USD | -281,976,000USD |
| Accumulated Other Comprehensive Income | 0USD | 1,000USD | 18,000USD | 24,000USD | 17,000USD | 47,000USD | 68,000USD | 169,000USD |
| Total Liab | — | 4,195,000USD | 4,305,000USD | 4,627,000USD | 5,039,000USD | 3,910,000USD | 6,454,000USD | 8,189,000USD |
| Other Current Liab | — | 3,101,000USD | 3,791,000USD | 3,736,000USD | 4,226,000USD | 2,546,000USD | 4,962,000USD | 10,138,000USD |
| Capital Stock | — | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Cash | — | 41,299,000USD | 31,374,000USD | 32,122,000USD | 9,445,000USD | 14,779,000USD | 13,903,000USD | 25,320,000USD |
| Net Debt | — | -41,145,000USD | -31,198,000USD | -31,924,000USD | -9,387,000USD | -14,663,000USD | -13,749,000USD | -25,090,000USD |
| Short Long Term Debt Total | — | 154,000USD | 176,000USD | 198,000USD | 58,000USD | 116,000USD | 154,000USD | 230,000USD |
| Property Plant Equipment Gross | — | 172,000USD | 678,000USD | 224,000USD | 112,000USD | 189,000USD | 921,000USD | 346,000USD |
| Common Stock Shares Outstanding | — | 5,688,584shares | 5,283,321shares | 5,632,324shares | 5,605,143shares | 5,596,825shares | 5,582,577shares | 5,574,153shares |
| Non Current Assets Total | — | 982,000USD | 1,008,000USD | 1,034,000USD | 738,000USD | 602,000USD | 267,000USD | 777,000USD |
| Non Current Liabilities Total | — | 55,000USD | 82,000USD | 108,000USD | 0USD | 0USD | 212,000USD | 0USD |
| Non Currrent Assets Other | — | 810,000USD | 810,000USD | 810,000USD | 626,000USD | — | — | 431,000USD |
| Net Working Capital | — | 49,350,000USD | 57,030,000USD | 62,108,000USD | 45,226,000USD | 53,471,000USD | 61,599,000USD | 70,041,000USD |
| Unclassified Equity | — | 360,544,000USD | 359,928,000USD | 359,148,000USD | 358,101,000USD | 356,477,000USD | 354,598,000USD | 352,617,000USD |
| Current Deferred Revenue | — | — | 212,000USD | 424,000USD | 636,000USD | 848,000USD | 848,000USD | 1,097,000USD |
| Long Term Investments | — | — | — | — | 626,000USD | 413,000USD | 0USD | 431,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -3,859,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 62,261,000USD | 68,108,000USD | 115,620,000USD | 180,435,000USD | 182,185,000USD | 141,858,000USD | 21,607,000USD |
| Other Current Assets | 6,517,000USD | 2,330,000USD | 4,860,000USD | 10,502,000USD | 5,535,000USD | 1,028,000USD | 1,462,000USD |
| Total Liab | 4,305,000USD | 6,454,000USD | 9,436,000USD | 11,118,000USD | 6,583,000USD | 5,855,000USD | 4,747,000USD |
| Total Stockholder Equity | 57,956,000USD | 61,654,000USD | 106,184,000USD | 169,317,000USD | 175,602,000USD | 136,003,000USD | 16,860,000USD |
| Other Current Liab | 3,791,000USD | 4,962,000USD | 8,068,000USD | 9,449,000USD | 5,948,000USD | 4,264,000USD | 2,949,000USD |
| Common Stock | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 3,000USD | 2,000USD | 230,000USD |
| Capital Stock | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 3,000USD | 2,000USD | — |
| Retained Earnings | -301,998,000USD | -293,020,000USD | -235,245,000USD | -160,681,000USD | -94,027,000USD | -47,014,000USD | -20,567,000USD |
| Cash | 31,374,000USD | 13,903,000USD | 24,494,000USD | 56,958,000USD | 175,334,000USD | 140,233,000USD | 19,458,000USD |
| Cash And Short Term Investments | 54,736,000USD | 65,511,000USD | 109,929,000USD | 168,994,000USD | 175,334,000USD | 140,233,000USD | 19,458,000USD |
| Total Current Assets | 61,253,000USD | 67,841,000USD | 114,789,000USD | 179,496,000USD | 180,869,000USD | 141,261,000USD | 20,920,000USD |
| Total Current Liabilities | 4,223,000USD | 6,242,000USD | 9,263,000USD | 10,744,000USD | 6,551,000USD | 5,843,000USD | 3,806,000USD |
| Current Deferred Revenue | 212,000USD | 848,000USD | — | — | — | — | — |
| Net Debt | -31,198,000USD | -13,749,000USD | -24,102,000USD | -56,403,000USD | -175,334,000USD | -140,233,000USD | -19,458,000USD |
| Short Term Debt | 94,000USD | 154,000USD | 219,000USD | 181,000USD | — | — | — |
| Short Long Term Debt Total | 176,000USD | 154,000USD | 392,000USD | 555,000USD | — | — | — |
| Short Term Investments | 23,362,000USD | 51,608,000USD | 85,435,000USD | 112,036,000USD | 0USD | — | — |
| Accounts Payable | 126,000USD | 278,000USD | 976,000USD | 1,114,000USD | 603,000USD | 1,579,000USD | 857,000USD |
| Property Plant Equipment Net | 198,000USD | 267,000USD | 592,000USD | 909,000USD | 511,000USD | 287,000USD | 199,000USD |
| Property Plant Equipment Gross | 678,000USD | 921,000USD | 1,115,000USD | 1,282,000USD | 717,000USD | 287,000USD | 199,000USD |
| Accumulated Other Comprehensive Income | 18,000USD | 68,000USD | 15,000USD | -214,000USD | 0USD | -230,031,000USD | 56,000USD |
| Common Stock Shares Outstanding | 5,629,370shares | 5,443,125shares | 5,055,924shares | 3,977,664shares | 4,016,246shares | 2,780,610shares | 2,780,610shares |
| Non Current Assets Total | 1,008,000USD | 267,000USD | 831,000USD | 939,000USD | 1,316,000USD | 597,000USD | 687,000USD |
| Non Current Liabilities Total | 82,000USD | 212,000USD | 173,000USD | 374,000USD | 32,000USD | 12,000USD | 941,000USD |
| Non Currrent Assets Other | 810,000USD | — | 239,000USD | 30,000USD | 805,000USD | — | — |
| Net Working Capital | 57,030,000USD | 61,599,000USD | 105,526,000USD | 168,752,000USD | 174,318,000USD | 135,418,000USD | 17,114,000USD |
| Unclassified Equity | 359,928,000USD | 354,598,000USD | 341,406,000USD | 330,204,000USD | 269,623,000USD | 413,044,000USD | 37,141,000USD |
| Long Term Investments | — | 0USD | 239,000USD | 30,000USD | 805,000USD | 310,000USD | 488,000USD |
| Net Tangible Assets | — | — | — | 169,317,000USD | 175,602,000USD | -46,024,000USD | -20,281,000USD |
| Other Liab | — | — | — | — | 32,000USD | 12,000USD | 941,000USD |
| Other Assets | — | — | — | — | 182,185,000USD | — | 0USD |
| Unclassified Non Current Assets | — | — | — | — | -182,990,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,278,000USD | -5,852,000USD | 16,016,000USD | -9,703,000USD | -9,439,000USD | -11,044,000USD | -11,466,000USD | -16,236,000USD |
| Depreciation | 3,000USD | 3,000USD | 35,000USD | 26,000USD | 28,000USD | 30,000USD | 32,000USD | 34,000USD |
| Stock Based Compensation | 613,000USD | 774,000USD | 1,047,000USD | 1,614,000USD | 1,879,000USD | 1,963,000USD | 2,027,000USD | 1,915,000USD |
| Other Non Cash Items | -51,000USD | -97,000USD | -22,463,000USD | 134,000USD | 377,000USD | 114,000USD | 963,000USD | 71,000USD |
| Change In Working Capital | -265,000USD | 493,000USD | -1,185,000USD | -450,000USD | -3,050,000USD | -925,000USD | -5,101,000USD | 3,798,000USD |
| Total Cash From Operating Activities | -7,978,000USD | -4,679,000USD | -6,550,000USD | -8,379,000USD | -10,205,000USD | -9,862,000USD | -13,545,000USD | -10,418,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -7,978,000USD | -4,679,000USD | -6,550,000USD | -8,379,000USD | -10,205,000USD | -9,862,000USD | -13,545,000USD | -10,418,000USD |
| Investments | 17,900,000USD | 3,925,000USD | 29,227,000USD | 3,035,000USD | 11,081,000USD | -1,573,000USD | 22,205,000USD | 2,596,000USD |
| Total Cashflows From Investing Activities | 17,900,000USD | 3,925,000USD | 29,227,000USD | 3,035,000USD | 11,081,000USD | -1,573,000USD | 22,205,000USD | 2,596,000USD |
| Total Cash From Financing Activities | 3,000USD | 6,000USD | 0USD | 10,000USD | 0USD | 18,000USD | -11,000USD | 5,192,000USD |
| Change In Cash | 9,925,000USD | -748,000USD | 22,677,000USD | -5,334,000USD | 876,000USD | -11,417,000USD | 8,649,000USD | -2,630,000USD |
| Begin Period Cash Flow | 31,374,000USD | 32,122,000USD | 9,445,000USD | 14,779,000USD | 13,903,000USD | 25,320,000USD | 16,671,000USD | 19,301,000USD |
| End Period Cash Flow | 41,299,000USD | 31,374,000USD | 32,122,000USD | 9,445,000USD | 14,779,000USD | 13,903,000USD | 25,320,000USD | 16,671,000USD |
| Other Cashflows From Financing Activities | 3,000USD | 6,000USD | — | — | — | 18,000USD | -11,000USD | 5,192,000USD |
| Sale Purchase Of Stock | — | 6,000USD | — | 10,000USD | — | 18,000USD | 44,000USD | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | 0USD | 0USD | — |
| Other Cashflows From Investing Activities | — | 1,000,000USD | 20,000,000USD | -1,500,000USD | — | — | -3,500,000USD | 2,596USD |
| Unclassified Investing Cash Flow | — | — | -20,000,000USD | 1,500,000USD | — | — | 3,500,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -8,978,000USD | -57,775,000USD | -74,564,000USD | -66,654,000USD | -47,013,000USD | -26,447,000USD | -17,563,000USD |
| Depreciation | 92,000USD | 131,000USD | 150,000USD | 167,000USD | 109,000USD | 62,000USD | 26,000USD |
| Stock Based Compensation | 5,314,000USD | 7,993,000USD | 10,920,000USD | 9,499,000USD | 3,645,000USD | 704,000USD | 194,000USD |
| Other Non Cash Items | -22,049,000USD | 627,000USD | -1,048,000USD | 640,000USD | 1,505,000USD | 1,522,000USD | 144,000USD |
| Change In Working Capital | -4,192,000USD | -258,000USD | 4,277,000USD | -936,000USD | -3,779,000USD | 2,120,000USD | 2,070,000USD |
| Total Cash From Operating Activities | -29,813,000USD | -49,282,000USD | -60,265,000USD | -57,284,000USD | -45,533,000USD | -22,039,000USD | -15,026,000USD |
| Capital Expenditures | 0USD | 0USD | -12,000USD | -54,000USD | -333,000USD | -137,000USD | -188,000USD |
| Free Cash Flow | -29,813,000USD | -49,282,000USD | -60,277,000USD | -57,338,000USD | -45,866,000USD | -22,176,000USD | -15,214,000USD |
| Investments | 28,768,000USD | 33,492,000USD | -19,897,000USD | -112,116,000USD | -2,000,000USD | -1,935,000USD | -1,935,000USD |
| Total Cashflows From Investing Activities | 47,268,000USD | 33,492,000USD | 27,658,000USD | -112,170,000USD | -2,333,000USD | -2,072,000USD | -188,000USD |
| Total Cash From Financing Activities | 16,000USD | 5,199,000USD | 143,000USD | 51,078,000USD | 82,967,000USD | 144,886,000USD | 31,567,000USD |
| Sale Purchase Of Stock | 16,000USD | 62,000USD | 282,000USD | 217,000USD | 82,967,000USD | — | — |
| Issuance Of Capital Stock | 0USD | 5,405,000USD | 0USD | 51,533,000USD | 86,200,000USD | 145,205,000USD | 31,600,000USD |
| Change In Cash | 17,471,000USD | -10,591,000USD | -32,464,000USD | -118,376,000USD | 35,101,000USD | 120,775,000USD | 16,353,000USD |
| Begin Period Cash Flow | 13,903,000USD | 24,494,000USD | 56,958,000USD | 175,334,000USD | 140,233,000USD | 19,458,000USD | 3,105,000USD |
| End Period Cash Flow | 31,374,000USD | 13,903,000USD | 24,494,000USD | 56,958,000USD | 175,334,000USD | 140,233,000USD | 19,458,000USD |
| Other Cashflows From Investing Activities | 18,500,000USD | -2,000,000USD | 2,250,000USD | -112,116USD | -2,000USD | -1,935USD | — |
| Other Cashflows From Financing Activities | 16,000USD | -206,000USD | 143,000USD | -455,000USD | -3,233,000USD | -319,000USD | -33,000USD |
| Unclassified Investing Cash Flow | — | 2,000,000USD | 45,317,000USD | — | — | — | 1,935,000USD |
| Unclassified Financing Cash Flow | — | 5,343,000USD | — | 51,316,000USD | 3,233,000USD | — | — |
| Change To Liabilities | — | — | — | 3,709,000USD | 728,000USD | 723,000USD | 728,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -118,376,000USD | 35,101,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.